Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
216.3 USD | +2.04% | -0.83% | -16.40% |
Mar. 25 | Dyne Therapeutics President, CEO Joshua Brumm Resigns, John Cox Named Successor; Shares Drop 7% Pre-Bell | MT |
Mar. 19 | BIOGEN : Jefferies confirms its Buy rating on the stock | CF |
- Stock
- Equities
- Stock Biogen Inc. - Nasdaq
- News Biogen Inc.